Meda to Buy Medpointe for $520M, Shares - Forbes
Meda to Buy Medpointe for $520M, SharesForbes, NY - Jul 20, 2007Its biggest products are Astelin, a nasal spray, and Optivar, which treats allergic conjunctivitis. "The new trans-Atlantic combination will enable Meda to …
Read full story